{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T14:52:01Z","timestamp":1787755921598,"version":"build-2784847793"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T00:00:00Z","timestamp":1738022400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Type 2 diabetes (T2DM) combined with fatty liver is a subtype of metabolic fatty liver disease (MAFLD), and the relationship between T2DM and MAFLD is close and mutually influential. However, the connection and mechanisms between the two are still unclear. Therefore, we aimed to identify potential biomarkers for diagnosing both conditions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed differential expression analysis and weighted gene correlation network analysis (WGCNA) on publicly available data on the two diseases in the Gene Expression Omnibus database to find genes related to both conditions. We utilised protein\u2013protein interactions (PPIs), Gene Ontology, and the Kyoto Encyclopedia of Genes and Genomes to identify T2DM-associated MAFLD genes and potential mechanisms. Candidate biomarkers were screened using machine learning algorithms combined with 12 cytoHubba algorithms, and a diagnostic model for T2DM-related MAFLD was constructed and evaluated.The CIBERSORT method was used to investigate immune cell infiltration in MAFLD and the immunological significance of central genes. Finally, we collected whole blood from patients with T2DM-related MAFLD, MAFLD patients and healthy individuals, and used high-fat, high-glucose combined with high-fat cell models to verify the expression of hub genes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Differential expression analysis and WGCNA identified 354 genes in the MAFLD dataset. The differential expression analysis of the T2DM-peripheral blood mononuclear cells\/liver dataset screened 91 T2DM-associated secreted proteins. PPI analysis revealed two important modules of T2DM-related pathogenic genes in MAFLD, which contained 49 nodes, suggesting their involvement in cell interaction, inflammation, and other processes. TNFSF10, SERPINB2, and TNFRSF1A were the only coexisting genes shared between MAFLD key genes and T2DM-related secreted proteins, enabling the construction of highly accurate diagnostic models for both disorders. Additionally, high-fat, high-glucose combined with high-fat cell models were successfully produced. The expression patterns of TNFRSF1A and SERPINB2 were verified in patient blood and our cellular model. Immune dysregulation was observed in MAFLD, with TNFRSF1A and SERPINB2 strongly linked to immune regulation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The sensitivity and accuracy in diagnosing and predicting T2DM-associated MAFLD can be greatly improved using SERPINB2 and TNFRSF1A. These genes may significantly influence the development of T2DM-associated MAFLD, offering new diagnostic options for patients with T2DM combined with MAFLD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2025.1512503","type":"journal-article","created":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T00:11:25Z","timestamp":1738023085000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Identification of biomarkers for the diagnosis of type 2 diabetes mellitus with metabolic associated fatty liver disease by bioinformatics analysis and experimental validation"],"prefix":"10.3389","volume":"16","author":[{"given":"Guiling","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sihui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liheng","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuihong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinghuan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingfen","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,1,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"key":"B2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/s2468-1253(22)00165-0","article-title":"The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis","volume":"7","author":"Riazi","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(22)00078-x","article-title":"Clinical characteristics, surveillance, treatment allocation, and outcomes of non-alcoholic fatty liver disease-related hepatocellular carcinoma: a systematic review and meta-analysis","volume":"23","author":"Tan","year":"2022","journal-title":"Lancet Oncol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32758","article-title":"Global burden of liver cancer in males and females: Changing etiological basis and the growing contribution of NASH","volume":"77","author":"Tan","year":"2023","journal-title":"Hepatology"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell"},{"key":"B7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2017-313884","article-title":"Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases","volume":"66","author":"Adams","year":"2017","journal-title":"Gut"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J Hepatol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/s41575-021-00448-y","article-title":"The complex link between NAFLD and type 2 diabetes mellitus - mechanisms and treatments","volume":"18","author":"Targher","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/nature13478","article-title":"The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes","volume":"510","author":"Perry","year":"2014","journal-title":"Nature"},{"key":"B12","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s11892-021-01383-7","article-title":"The relationship between type 2 diabetes, NAFLD, and cardiovascular risk","volume":"21","author":"Caussy","year":"2021","journal-title":"Curr Diabetes Rep"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.01.014","article-title":"Type 2 diabetes and risk of hospital admission or death for chronic liver diseases","volume":"64","author":"Wild","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1053\/j.gastro.2023.04.025","article-title":"Fibrosis progression rate in biopsy-proven nonalcoholic fatty liver disease among people with diabetes versus people without diabetes: A multicenter study","volume":"165","author":"Huang","year":"2023","journal-title":"Gastroenterology"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gks1193","article-title":"NCBI GEO: archive for functional genomics data sets\u2013update","volume":"41","author":"Barrett","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btm254","article-title":"GEOquery: a bridge between the gene expression omnibus (GEO) and bioConductor","volume":"23","author":"Davis","year":"2007","journal-title":"Bioinformatics"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-9-559","article-title":"WGCNA: an R package for weighted correlation network analysis","volume":"9","author":"Langfelder","year":"2008","journal-title":"BMC Bioinf"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/nbt1210-1248","article-title":"Towards a knowledge-based human protein atlas","volume":"28","author":"Uhlen","year":"2010","journal-title":"Nat Biotechnol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","article-title":"The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest","volume":"51","author":"Szklarczyk","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"Omics"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v033.i01","article-title":"Regularization paths for generalized linear models via coordinate descent","volume":"33","author":"Friedman","year":"2010","journal-title":"J Stat Softw"},{"key":"B25","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1186\/s12859-018-2451-4","article-title":"SVM-RFE: selection and visualization of the most relevant features through non-linear kernels","volume":"19","author":"Sanz","year":"2018","journal-title":"BMC Bioinf"},{"key":"B26","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1002\/jmri.26187","article-title":"RF coils: A practical guide for nonphysicists","volume":"48","author":"Gruber","year":"2018","journal-title":"J Magn Reson Imaging"},{"key":"B27","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1186\/1752-0509-8-s4-s11","article-title":"cytoHubba: identifying hub objects and sub-networks from complex interactome","author":"Chin","year":"2014","journal-title":"BMC Syst Biol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1002\/imt2.5","article-title":"ImageGP: An easy-to-use data visualization web server for scientific researchers","volume":"1","author":"Chen","year":"2022","journal-title":"Imeta"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/90.10.766","article-title":"A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer","volume":"90","author":"Kattan","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.3337","article-title":"Robust enumeration of cell subsets from tissue expression profiles","volume":"12","author":"Newman","year":"2015","journal-title":"Nat Methods"},{"key":"B31","volume-title":"R package 'corrplot': Visualization of a Correlation Matrix","author":"Wei","year":"2024"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2017.6450","article-title":"Epigallocatechin-3-gallate ameliorates insulin resistance in hepatocytes","volume":"15","author":"Ma","year":"2017","journal-title":"Mol Med Rep"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/j.cmet.2023.04.011","article-title":"Organism-wide, cell-type-specific secretome mapping of exercise training in mice","volume":"35","author":"Wei","year":"2023","journal-title":"Cell Metab"},{"key":"B34","doi-asserted-by":"publisher","first-page":"4257","DOI":"10.1038\/s41467-023-39710-z","article-title":"The muscle-enriched myokine Musclin impairs beige fat thermogenesis and systemic energy homeostasis via Tfr1\/PKA signaling in male mice","volume":"14","author":"Jin","year":"2023","journal-title":"Nat Commun"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3148.2006.00673.x","article-title":"Diagnostic applications of microarrays","volume":"16","author":"Petrik","year":"2006","journal-title":"Transfus Med"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1586\/erm.11.3","article-title":"Next-generation sequencing and its applications in molecular diagnostics","volume":"11","author":"Su","year":"2011","journal-title":"Expert Rev Mol Diagn"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.bioeng.8.061505.095802","article-title":"Machine learning for detection and diagnosis of disease","volume":"8","author":"Sajda","year":"2006","journal-title":"Annu Rev BioMed Eng"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00045.2017","article-title":"The TNF family of ligands and receptors: communication modules in the immune system and beyond","volume":"99","author":"Dostert","year":"2019","journal-title":"Physiol Rev"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26046","article-title":"Tumor necrosis factor receptor 1 gain-of-function mutation aggravates nonalcoholic fatty liver disease but does not cause insulin resistance in a murine model","volume":"57","author":"Aparicio-Vergara","year":"2013","journal-title":"Hepatology"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v26.i33.4933","article-title":"Tumor necrosis factor alpha receptor 1 deficiency in hepatocytes does not protect from non-alcoholic steatohepatitis, but attenuates insulin resistance in mice","volume":"26","author":"Bluemel","year":"2020","journal-title":"World J Gastroenterol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jnutbio.2018.04.013","article-title":"Disruption of tumor necrosis factor alpha receptor 1 signaling accelerates NAFLD progression in mice upon a high-fat diet","volume":"58","author":"Lambertucci","year":"2018","journal-title":"J Nutr Biochem"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V86.11.4007.bloodjournal86114007","article-title":"Biological and clinical aspects of plasminogen activator inhibitor type 2","volume":"86","author":"Kruithof","year":"1995","journal-title":"Blood"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-4658.2005.04879.x","article-title":"The undecided serpin. The ins and outs of plasminogen activator inhibitor type 2","volume":"272","author":"Medcalf","year":"2005","journal-title":"FEBS J"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.204974","article-title":"The serine protease inhibitor serpinB2 binds and stabilizes p21 in senescent cells","volume":"130","author":"Hsieh","year":"2017","journal-title":"J Cell Sci"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1111\/acel.12344","article-title":"The Achilles\u2019 heel of senescent cells: from transcriptome to senolytic drugs","volume":"14","author":"Zhu","year":"2015","journal-title":"Aging Cell"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1207834","article-title":"Disparate effects of telomere attrition on gene expression during replicative senescence of human mammary epithelial cells cultured under different conditions","volume":"23","author":"Zhang","year":"2004","journal-title":"Oncogene"},{"key":"B47","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1055\/s-0031-1276589","article-title":"Forty years later and the role of plasminogen activator inhibitor type 2\/SERPINB2 is still an enigma","volume":"37","author":"Lee","year":"2011","journal-title":"Semin Thromb Hemost"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0902187","article-title":"A physiological function of inflammation-associated SerpinB2 is regulation of adaptive immunity","volume":"184","author":"Schroder","year":"2010","journal-title":"J Immunol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-021-06774-3","article-title":"RNA sequencing of LX-2 cells treated with TGF-\u03b21 identifies genes associated with hepatic stellate cell activation","volume":"48","author":"Carson","year":"2021","journal-title":"Mol Biol Rep"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2011.05.014","article-title":"Liver transcriptional profile of atherosclerosis-related genes in human nonalcoholic fatty liver disease","volume":"218","author":"Sookoian","year":"2011","journal-title":"Atherosclerosis"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.2147\/dmso.S262950","article-title":"Effect of insulin-regulated FOXC2 expression in adipocyte differentiation and insulin resistance","volume":"13","author":"Zhang","year":"2020","journal-title":"Diabetes Metab Syndr Obes"},{"key":"B52","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/labinvest.2014.3","article-title":"Increased expression of c-Jun in nonalcoholic fatty liver disease","volume":"94","author":"Dorn","year":"2014","journal-title":"Lab Invest"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2018.12.003","article-title":"Hepatic c-Jun regulates glucose metabolism via FGF21 and modulates body temperature through the neural signals","volume":"20","author":"Xiao","year":"2019","journal-title":"Mol Metab"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.62625","article-title":"Enhanced C\/EBP\u03b2 function promotes hypertrophic versus hyperplastic fat tissue growth and prevents steatosis in response to high-fat diet feeding","volume":"11","author":"M\u00fcller","year":"2022","journal-title":"Elife"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1512503\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T00:11:38Z","timestamp":1738023098000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1512503\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,28]]},"references-count":54,"alternative-id":["10.3389\/fendo.2025.1512503"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1512503","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,28]]},"article-number":"1512503"}}